- This topic has 11,679 replies, 48 voices, and was last updated 3 weeks, 4 days ago by .
-
Forte Biosciences – FBRX
Forte Biosciences soars; company says private placement of $53 mln shares oversubscribed
If we had some inside info 😀
** Shares of drug developer Forte Biosciences FBRX rise 132.4% to $13.77** Company says private placement of its shares, worth $53 mln, oversubscribed
** Funds to support development of company’s experimental drug, FB102, to treat autoimmune diseases – FBRX
** Received support from new and existing investors, including OrbiMed, Janus Henderson Investors and Tybourne Capital Management – CEO Paul Wagner
** Despite session’s gains, stock down 34.2% YTD
Target Corporation – TGT
Target Margins And Inventory Issues Raise Analyst Caution After Weak Q3 Performance
Target took a dive  and is within the biggest losers of the day.
Target Corporation TGT shares are trading lower on Wednesday after it reported weak third-quarter results and slashed FY24 outlook.The company reported third-quarter adjusted earnings per share of $1.85, missing the street view of $2.30.
For FY24, the company now forecasts adjusted EPS between $8.30 and $8.90, down from the previous guidance of $9.00 to $9.70. The revised FY24 EPS outlook is also below the consensus estimate of $9.55.
NIO Inc.
On the edge of breaking Up ?
Nio’s stock dives as earnings, outlook disappoint despite record deliveries
The U.S.-listed shares of Nio Inc. took a dive in early Wednesday trading, after the China-based battery electric-vehicle maker reported disappointing third-quarter results, as they missed expectations despite record deliveries.The company (NIO) also provided a revenue outlook for the current quarter that was below Wall Street forecasts, while deliveries were seen rising to another record.
SOLUSD – Solana
Solana (SOL) Price Pattern Points to Brief Dip, $260 Target Next
Sol value could face a setback before its potential rise toward $260. At press time, SOL’s value is $237.88, representing a 15% hike in the last seven days.While SOL holders would expect the rally to continue, several technical indicators suggest that they might need to wait a little longer.
Solana Uptrend Pulls Back
Nvidia – NVDA
PREVIEW: Nvidia shares ease – results due after the bell
Shares of Nvidia NVDA down 1.4% in afternoon trading ahead of the key AI chipmaker’s quarterly results due after the closing bell
** Analysts expect the co to report a rise in quarterly rev to $33.16 bln vs $18.12 bln in the yr-ago qtr, and EPS of 75c/shr vs 40c a yr ago, according to LSEG
** Analyst recommendations on the stock include 57 “strong buy” or “buy” ratings, six “hold” ratings and no “sell” or “strong sell” ratings, based on LSEG data
** Including the session move, the stock is up 193% for the YTD
- You must be logged in to reply to this topic.